The objective of targeting technologies in the field of nanomedicine is to specifically focus therapies on diseased cells in order to deliver the treatment to these cells without harming healthy ones. The use of magnetic materials in such biomedical applications offers many advantages. They can be functionalized with an agent that enhances the biocompatibility and the targeting while, at the same time, they can be controlled and monitored remotely. Iron nanowires (Fe NWs), which usually have a native oxide shell, are specifically attractive, since they are highly biocompatible, strongly magnetic, and can be coated with different biological agents. Shape anisotropy makes these NWs permanently magnetic and, therefore, can be exploited for multifaceted remote manipulations, rendering them versatile nano-robots. As such, they have been used before in combination with a magnetic field to induce cancer cell death. In order to minimize the side effects of this method, this paper aims to enhance the targeting ability of these NWs toward particular cells. Specifically, leukemic cells are targeted by functionalizing Fe NWs with anti-CD44 antibodies, a cell surface marker, which is overexpressed in leukemic cells compared to healthy blood cells. Fe NWs were electrochemically fabricated with an average diameter of 35 nm and a length around 3 µm. They were coated with bovine serum albumin to facilitate their conjugation covalently with an anti-CD44 antibody by using 3-(3-dimethyl-aminopropyl) carbodiimide and of N-hydroxysuccinimide. In order to confirm the presence of anti-CD44 antibodies on the surface of the NWs, immunostaining and Fourier transform infrared spectroscopy were used. In addition, cytotoxicity effects of bare Fe NWs and coated and functionalized NWs were studied by using cell proliferation assays. These studies illustrated that the NWs have a high level of biocompatibility.
I. INTRODUCTION
T HE use of magnetic nanostructures for biomedical applications has significantly increased in the past few years. Magnetic nanowires (NWs) have similar advantages as commonly used superparamagnetic iron oxide nanoparticles [1] when it comes to biocompatibility [2] , and functionalization [3] . Their length and diameter can be easily modified, depending on the method of fabrication and the materials available [4] . The shape of the NWs has two important consequences, changing the properties compared to the nanoparticles: 1) the NWs have larger remnant magnetic moments, which enhance the remote controllability of their movement by magnetic fields [5] , [6] . This property has been used to induce cancer cell death by a magneto-mechanical effect and 2) the larger surface area to volume ratios, which increases the capabilities for surface modifications [7] - [10] . In this paper, modifying the NWs' surface can provide attachment links for functional agents, such as antibodies, which enhance the specific targeting [11] , drugs [10] , or dyes [12] .
Although a large number of studies have focused on Nickel NWs, these NWs have been shown to have genotoxic and cytotoxic effects [13] , [14] . In contrast, iron NWs (Fe NWs) have shown a high level of biocompatibility, even at high concentrations and long incubation times with the cells [9] , [10] , [15] . The iron oxide shell that forms either as a native passivation or by annealing [2] plays a major role in this biocompatibility [10] . While it can also affect the NW's magnetization [2] , this effect usually plays a minor role, due to the small amount of volume oxidized. In a study of Fe NWs loaded with the chemotherapeutic drug, doxorubicin, it was shown that cancer cells were killed efficiently by drug delivery in combination with magneto-mechanical stimulation [10] . In order to provide a selective treatment and minimize the side effects on healthy cells, functionalization of the Fe NWs, e.g., with antibodies, to target cell surface receptors, is required.
Acute myeloid leukemia is a blood cancer caused by genetic defects in hematopoietic progenitor cells (HPCs). These genetic changes block the differentiation pathway of HPCs, resulting in immature nonfunctional blood cells that possess an uncontrolled proliferation [16] . In addition, CD44 cell surface markers are highly expressed on leukemic cells, compared to normal blood cells [17] . Thus, the goal of this paper was to functionalize Fe NWs with monoclonal anti-CD44 antibodies to target CD44 markers on leukemic cells. This approach is expected to significantly increase the probability of specific targeting of cancer cells without harming healthy cells.
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II. EXPERIMENTAL METHODS

A. Nanowire Fabrication
The fabrication of Fe NWs is based on electrode position into alumina templates, which is accomplished in six steps. First, a pure aluminum disk (GoodFellow) with a diameter of 2.5 mm and a thickness of 0.5 mm was electropolished by using a 70% perchloric acid solution with a voltage of 20 V. Then, an anodization was carried out with 0.3 M oxalic acid at 4°C, applying a voltage of 40 V for 24 h. This step grows an alumina layer and establishes pores that unorganized in arrangement and diameter at the surface, but regularly aligned at the bottom. Then, the membrane was incubated in 0.2 M chromium trioxide (CrO 3 ) for 12 h at 40°C, in order to remove the alumina layer. This leaves aluminum disk with hexagonally ordered indentations. In the fourth step, a second anodization grows another alumina layer with uniformly arranged pores that originated from the indentations. This anodization step is carried out for 4 h using the same conditions as the first anodization and resulting in 5 µm deep pores. Thereafter, the bottoms of the pores were connected to the aluminum substrate via the growth of dendrites. Before the last step, the template was filled with an iron solution that is made of 13.9 g iron sulfate (FeSO 4 ), 7.45 g sodium sulfate (Na 2 SO 4 ), 2.47-g boric acid (H 3 BO 3 ), and 0.16 g ascorbic acid (C 6 H 8 O 6 ) dissolved in 100 ml distilled water. Finally, the NWs were grown by applying pulsed electrodeposition (−60 mA pulses of 2 ms duration) for 1 h at room temperature. The full explanation of the fabrication process can be found in previous studies [9] , [10] , [12] , [18] , [13] .
In order to release the NWs from the alumina, it was cut into pieces that were inserted into an Eppendorf tube and immersed in 1 ml of 1 M sodium hydroxide for 1 h. Then, the Al template pieces were removed and the solution was renewed every hour for four times with 10 s of sonication in between. To clean the NWs from the sodium hydroxide, they were rinsed six times using 96% ethanol with 10 s of sonication and then stored in the solution for the experiments [9] , [10] , [12] . The number of NWs contained in one disk was obtained by mixing 10 µl of the solution with the released NWs with 300 µl hydrochloric acid (37%) and incubating it for 20 min. Then, the volume was completed to 3 ml by adding distilled water. Inductively coupled plasma mass spectrometry was then used to quantify the Fe NW concentration. The schematic shown in Fig. 1(a) presents a summary of the NW fabrication process.
The morphology of Fe NWs was characterized by scanning electron microscopy (SEM, Quanta 3-D; FEI Company, Hillsboro, OR, USA) and transmission electron microscopy (TEM, Tecnai BioTWIN; FEI Company) was used to determine the diameter, length, and surface coating of the NWs. Electron energy loss spectroscopy (EELS) was used to characterized the iron (core) and iron oxide (shell). The samples for SEM, TEM, and EELS were prepared by taking 2 µl of NW solution in ethanol and placing it on a silicon substrate for SEM and on a copper-carbon mesh substrate for TEM. Then, the samples were investigated after complete drying. Moreover, the magnetic properties of the Fe NWs were characterized by measuring their hysteresis curves with a vibrating sample magnetometer (VSM).
B. Nanowires Coating and Functionalization
Fe NWs were coated with bovine serum albumen (BSA) by washing released Fe NWs three times with 10 mM phosphate buffer (PB) of pH 7.4. Then, they were immersed into BSA with a concentration (22 mg BSA/1 mg NWs) for 1.5 h under sonication. After that, the NWs were washed four times with PB and stored at 4°C for the further use.
The NW functionalization is based on a covalent conjugation between the amine group on the BSA coated NWs (i.e., BSA NWs) and the N-hydroxysuccinimide (NHS) ester group on the activated antibody. 990 µl of 25 µg/mL anti-CD44 antibody clone Hermes-3 (ABGENT) were incubated with 10 µl of fresh and cold crosslinking solutions for 20 min. This solution was prepared by dissolving 8 mg of 3-(3-dimethyl-aminopropyl) carbodiimide (EDC) and 22 mg of NHS in 1 mL of 2-(N-Morpholino) ethanesulfonic acid hydrate (0.1 M, pH 4.7). This interaction activates the antibody carboxyl groups. Then, the washed BSA NWs were incubated with activated antibodies for 2 h at room temperature. Finally, the functionalized Fe NWs (i.e., Ab NWs) were rinsed, blocked with 2% BSA and stored at 4°C. The biofunctionalization process is summarized in [Fig. 1(b) ].
C. Immunostaining
To confirm the antibody immobilization at the surface of the NWs, both BSA NWs and Ab NWs were incubated with 50 mg/ml of green fluorescent-labeled secondary antibody (DyLight 488 Goat anti-Mouse IgG (H + L): Thermo Fisher) for 1 h under 300 rpm shaking. The NWs were rinsed three times with PB, placed on a glass microscope slide, and sandwiched from the top by a coverslip. The images were investigated under the laser scanning confocal microscope (MTZ02-Leica TCS SP5) using 63× oil lens and ALEXA 488 laser.
D. Fourier Transform Infrared Spectroscopy
In order to analyze the characteristics of the functionalized Fe NWs, a similar amount of Fe NWs, BSA NWs, and Ab NWs were added on gold-coated microscope slides (Thermo Fisher Scientific) and left to dry for 5 min at room temperature. The samples were detected with a Nicolet Continuum FTIR microscope and OMIC software was used to analyze the data.
E. Cell Culturing
An acute myeloid leukemia cell line HL60 (ATCC CCL¬240) was cultured in RPMI 1640 with 10% fetal bovine serum and 5 ml penicillin-streptomycin. All of the supplements and the media were bought from (GIBCO life technologies). The cells were grown inside the incubator under a humidified environment with 5% CO 2 at 37°C.
F. Biocompatibility Study
Leukemic cells were grown in 96-flat well plates with a concentration of 100 000 cell/ml. Before treating the cells, the NWs were washed three times with PB followed by four washing steps with warmed RPMI media. 250 NWs/cell (i.e., 7.42E-04 µg Fe/ml) were added per well and incubated with the cells for 24 h. The 2, 3-Bis (2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carbanilide (XTT) cell proliferation assay was applied to the cells by following the kit protocol (TACS XTT Cell Proliferation Assay Cat# 4891-025-K, 2500 Tests). After warming up both XTT reagent and the activator at 37°C, 100 µl of the XTT activator were mixed with 5 mL of XTT reagent. Then, 50 µl of the prepared XTT working solution was added to each well and incubated for 2 h at 37°C. The result was obtained by reading the 96-well plate in the microplate reader at 490 nm with a reference wavelength of 630 nm. All the experiments have been done in triplicates.
III. RESULTS AND DISCUSSION
A. Nanowires Characterization
Inductively coupled plasma mass spectrometry results revealed that each alumina disk contained around 0.6 µg of NWs, which corresponds to 5.6 E + 10 NWs of 40 nm in diameter and 3 µm in length. The morphology of the released NWs is shown in Figs. 2(a) and 3(a) . In Fig. 3(a) , an iron oxide layer surrounding the NWs can be seen, which has previously been identified as Fe 2 O 3 phase [10] . The thickness of this layer is around 3.5 nm, which is formed during and after the release step [8] , due to the exposure to the air, while releasing and washing with absolute ethanol [5] . This oxide interphase can be used for the attachment of coating agents to the NWs' surface.
VSM has been used to characterize the magnetic properties of Fe NWs embedded in the alumina template. Fig 2(b) shows the hysteresis loop, with a saturation magnetization (M s ) of 427 Am 2 /kg and a coercive field of (H c ) 138.4 kA/m for the field applied parallel to the NWs (easy axis). The large remanent magnetization (M R ) of 388 Am 2 /kg confirms the permanent magnetic properties of the NWs.
B. Nanowire Coating and Functionalization
In order to immobilize the biological agents, i.e., antibodies, on the Fe NWs, amine groups on the surface of the NWs are utilized. This has been achieved by coating the NWs with BSA. The coating was confirmed by TEM imaging [ Fig. 3(b) ]. To determine the immobilization of anti-CD44 antibodies onto the Fe NWs, two approaches were applied. The first one was using secondary antibodies that target only the functionalized NWs. A strong signal observed on Ab NWs [ Fig. 3(c) ] and no signal from non-functionalized, i.e., BSA NWs, [ Fig. 3(d) ] confirms the functionalization.
The second method was using Fourier transform infrared spectroscopy (FTIR) in order to detect the functional groups that were formed after the antibody attachment. In theory, an amide group (R-CO-NH) should be created after the interaction between carboxyl and ester groups [19] . Indeed, as shown in Fig. 4(c) , the formation of the amide group is obtained in the Ab NWs. The signal at 1542 cm −1 stems from amide II (C-N-H) groups [20] and is only found in the case of Ab NWs. However, the peak at 1650 cm −1 was observed in both BSA NWs and Ab NWs and is attributed to the presence of amide I (C = O) groups [20] , [21] . The peaks at 3018 and 3020 cm −1 in both BSA NWs and Ab NWs, respectively, are attributed to the stretching of hydroxide (O-H) groups [20] , [21] that come from the BSA. These results confirm the immobilization of antibodies on the NWs.
C. Nanowire Biocompatibility
The cell viability assay, XTT, is based on the reduction of the tetrazolium salt XTT to formazan, which occurs through the succinate-tetrazolium reductase system in the mitochondria of metabolically active cells. The reaction is attributed mainly to mitochondrial enzymes and electron carriers [22] .
In our case, the XTT assay was used to study the toxicity of the NWs on leukemic cells. As shown in Fig. 5 , both BSA NWs and Ab NWs have a high level of biocompatibility compared to Fe-NWs. However, there is no significant decrease between Fe NWs and cells without any treatment, but it seems that the BSA and antibody coating further reduces the toxicity of the Fe NWs, which is already very low.
IV. CONCLUSION
Fe NWs have been fabricated by electrochemical deposition into alumina templates. A method for coating them with BSA and functionalization with anti-CD44 antibodies was developed. BSA was used as a linker molecule facilitating the attachment of anti-CD44 antibodies to the iron oxide shell of the NWs, which was confirmed by TEM image that showed a continuous layer of BSA around the NWs. In addition, immunostaining and FTIR confirmed the successful functionalization of the NWs with the antibodies. Combining these NWs with leukemic cancer cells showed a high level of biocompatibility of both BSA NWs and Ab NWs in vitro. Overall, the high biocompatibility of functionalized NWs and the ability of remotely controlling their movement by using the magnetic field make them a promising platform for targeted treatments.
